Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

82 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immunogenicity and tolerability of intradermal administration of an HCV E1-based vaccine candidate in healthy volunteers and patients with resolved or ongoing chronic HCV infection.
Leroux-Roels G, Batens AH, Desombere I, Van Den Steen B, Vander Stichele C, Maertens G, Hulstaert F. Leroux-Roels G, et al. Among authors: hulstaert f. Hum Vaccin. 2005 Mar-Apr;1(2):61-5. doi: 10.4161/hv.1.2.1554. Epub 2005 Mar 21. Hum Vaccin. 2005. PMID: 17038823 Clinical Trial.
Performance characteristics of updated INNO-LiPA assays for molecular typing of human leukocyte antigen A (HLA-A), HLA-B, and HLA-DQB1 alleles.
De Vreese K, Barylski R, Pughe F, Bläser M, Evans C, Norton J, Semana G, Holman R, Loiseau P, Masson D, Gielis M, De Brauwer A, De Canck I, Verpooten G, Hulstaert F. De Vreese K, et al. Among authors: hulstaert f. Clin Diagn Lab Immunol. 2004 Mar;11(2):430-2. doi: 10.1128/cdli.11.2.430-432.2004. Clin Diagn Lab Immunol. 2004. PMID: 15014000 Free PMC article.
Analytical performance and clinical utility of the INNOTEST PHOSPHO-TAU181P assay for discrimination between Alzheimer's disease and dementia with Lewy bodies.
Vanderstichele H, De Vreese K, Blennow K, Andreasen N, Sindic C, Ivanoiu A, Hampel H, Bürger K, Parnetti L, Lanari A, Padovani A, DiLuca M, Bläser M, Olsson AO, Pottel H, Hulstaert F, Vanmechelen E. Vanderstichele H, et al. Among authors: hulstaert f. Clin Chem Lab Med. 2006;44(12):1472-80. doi: 10.1515/CCLM.2006.258. Clin Chem Lab Med. 2006. PMID: 17163825
Virologic therapy response significantly correlates with the number of active drugs as evaluated using a LiPA HIV-1 resistance scoring system.
Ziermann R, Celis L, Derdelinckx I, Lambert C, Veeck J, Rizzo MG, Vanderborght B, Zissis G, Clumeck N, Fransen K, Vaira D, Hendricks D, Van Laethem K, Vandamme AM, Schmit JC, Knechten H, De Luca A, Louwagie J, Segers P, De Boeck K, Pottel H, De Brauwer A, Hulstaert F. Ziermann R, et al. Among authors: hulstaert f. J Clin Virol. 2004 Dec;31 Suppl 1:S7-15. doi: 10.1016/j.jcv.2004.09.014. J Clin Virol. 2004. PMID: 15567089 Free article.
Should chronic hepatitis B be treated as early as possible?
Hulstaert F, Schwierz C, Nevens F, Thiry N, Gamil M, Colle I, Van de Sande S, Horsmans Y. Hulstaert F, et al. Int J Technol Assess Health Care. 2013 Jan;29(1):35-41. doi: 10.1017/S0266462312000736. Epub 2013 Jan 8. Int J Technol Assess Health Care. 2013. PMID: 23298548
82 results